Raymond James & Associates’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Raymond James & Associates’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,097	Closed	-$938K	–	4158
2022 Q4	$938K	Hold	26,097	–	–	﹤0.01%	2464
2022 Q3	$393K	Hold	26,097	–	–	﹤0.01%	3008
2022 Q2	$349K	Buy	+26,097	New	+$414K	﹤0.01%	3137

Raymond James & Associates's IMGO Position: Q1 2023 in Review

Raymond James & Associates sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 26,097 shares — an estimated $938K sold.

Raymond James & Associates first reported a position in IMGO in Q2 2022 and held it in 3 quarters. The position peaked at $938K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Raymond James & Associates reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Raymond James & Associates sold 26,097 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $938K.
Raymond James & Associates first reported a position in Imago BioSciences, Inc. Common stock in Q2 2022 and held it in 3 quarters.
Raymond James & Associates's Imago BioSciences, Inc. Common stock position peaked at $938K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.